Long-term preclinical evaluation of the intracorporeal use of advanced local hemostatics in a damage-control swine model of grade IV liver injury

Journal of Trauma and Acute Care Surgery

Volumn 74, Issue 2, 2013, Pages 538-545

  Inaba, Kenji ^a   Branco, Bernardino C ^c   Rhee, Peter ^b   Putty, Bradley ^a   Okoye, Obi ^a   Barmparas, Galinos ^a   Talving, Peep ^a   Demetriades, Demetrios ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Damage control; Hemostatic; Liver; Long term; Topical

Indexed keywords

CHITOSAN DERIVATIVE; HEMOSTATIC AGENT; KAOLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY BLOOD VESSEL; EOSINOPHIL; EXPERIMENTAL PIG; GRANULATION TISSUE; HEMOSTASIS; HISTOPATHOLOGY; INTESTINE OBSTRUCTION; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL TIME;

ANIMALS; CHITOSAN; DISEASE MODELS, ANIMAL; FEMALE; HEMORRHAGE; HEMOSTATICS; INTESTINE, SMALL; KAOLIN; KIDNEY; LIVER; MYOCARDIUM; SWINE;

EID: 84875275768     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31827d5f5f     Document Type: Article

References (37)

1. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38:185-193.
2. Gruen RL, Jurkovich GJ, McIntyre LK, et al. Patterns of errors contributing to trauma mortality: lessons learned from 2, 594 deaths. Ann Surg. 2006;244:371-380.
3. Teixeira PG, Inaba K, Hadjizacharia P, et al. Preventable or potentially preventable mortality at a mature trauma center. J Trauma. 2007;63: 1338-1346; discussion 1346-1347.
4. Alam HB, Burris D, DaCorta JA, et al. Hemorrhage control in the battlefield: role of new hemostatic agents. Mil Med. 2005;170:63-69.
5. Pusateri AE, Holcomb JB, Kheirabadi BS, et al. Making sense of the preclinical literature on advanced hemostatic products. J Trauma. 2006; 60:674-682.
6. Cox ED, Schreiber MA, McManus J, et al. New hemostatic agents in the combat setting. Transfusion. 2009;49(Suppl 5):248S-255S.
7. Inaba K, Rhee P, Teixeira PG, et al. Intracorporeal use of advanced local hemostatics in a damage control swine model of grade IV liver injury. J Trauma. 2011;71:1312-1318.
8. Wright FL, Hua HT, Velmahos G, et al. Intracorporeal use of the hemo-static agent QuickClot in a coagulopathic patient with combined thor-acoabdominal penetrating trauma. J Trauma. 2004;56:205-208.
9. Rhee P, Brown C, Martin M, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma. 2008;64:1093-1099.
10. Shanmugam V, Robinson MH. Case report of uncontrollable pelvic bleedingVmanaged by a previously unreported method (QuikClot). Colorectal Dis. 2009;11:221-222.
11. Arnaud F, Tomori T, Carr W, et al. Exothermic reaction in zeolite hemo-static dressings: QuikClot ACS and ACS+. Ann Biomed Eng. 2008;36: 1708-1713.
12. Pusateri AE, Delgado AV, Dick EJ Jr, et al. Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine. J Trauma. 2004;57:555-562; discussion 562.
13. Pusateri AE, McCarthy SJ, Gregory KW, et al. Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma. 2003;54:177-182.
14. Bochicchio G, Kilbourne M, Kuehn R, et al. Use of a modified chitosan dressing in a hypothermic coagulopathic Grade V liver injury model. Am J Surg. 2009;198:617-622.
15. Bochicchio GV, Kilbourne MJ, Keledjian K, et al. Evaluation of a new hemostatic agent in a porcine Grade V liver injury model. Am Surg. 2010; 76:317-320.
16. Millner R, Lockhart AS, Marr R. Chitosan arrests bleeding in major hepatic injuries with clotting dysfunction: an in vivo experimental study in a model of hepatic injury in the presence of moderate systemic heparinisation. Ann R Coll Surg Engl. 2010;92:559-561.
17. Wright JK, Kalns J, Wolf EA, et al. Thermal injury resulting from application of a granular mineral hemostatic agent. J Trauma. 2004;57: 224-230.
18. Schnuriger B, Inaba K, Barmparas G, et al. A new survivable damage control model including hypothermia, hemodilution, and liver injury. J Surg Res. 2011;169:99-105.
19. Niles SE, McLaughlin DF, Perkins JG, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma. 2008;64:1459-1463; discussion 1463-1465.
20. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma. 2003;54:1127-1130.
21. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55:39-44.
22. Alam HB, Chen Z, Jaskille A, et al. Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in swine. J Trauma. 2004;56:974-983.
23. Acheson EM, Kheirabadi BS, Deguzman R, et al. Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. J Trauma. 2005;59:865-874; discussion 874-875.
24. Ahuja N, Ostomel TA, Rhee P, et al. Testing of modified zeolite hemostatic dressings in a large animal model of lethal groin injury. J Trauma. 2006; 61:1312-1320.
25. Ward KR, Tiba MH, Holbert WH, et al. Comparison of a new hemostatic agent to current combat hemostatic agents in a swine model of lethal extremity arterial hemorrhage. J Trauma. 2007;63:276-283; discussion 283-284.
26. Arnaud F, Tomori T, Saito R, et al. Comparative efficacy of granular and bagged formulations of the hemostatic agent QuikClot. J Trauma. 2007; 63:775-782.
27. Englehart MS, Cho SD, Tieu BH, et al. A novel highly porous silica and chitosan-based hemostatic dressing is superior to HemCon and gauze sponges. J Trauma. 2008;65:884-890; discussion 890-892.
28. Kheirabadi BS, Edens JW, Terrazas IB, et al. Comparison of new hemo-static granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine. J Trauma. 2009;66:316-326; discussion 327-328.
29. Sohn VY, Eckert MJ, Martin MJ, et al. Efficacy of three topical hemostatic agents applied by medics in a lethal groin injury model. J Surg Res. 2009;154:258-261.
30. Devlin JJ, Kircher S, Kozen BG, et al. Comparison of ChitoFlex(R), CELOX, and QuikClot(R) in Control of Hemorrhage. J Emerg Med. 2011;41:237-245.
31. Sambasivan CN, Cho SD, Zink KA, et al. A highly porous silica and chitosan-based hemostatic dressing is superior in controlling hemorrhage in a severe groin injury model in swine. Am J Surg. 2009;197:576-580; discussion 580.
32. Arnaud F, Parreno-Sadalan D, Tomori T, et al. Comparison of 10 hemostatic dressings in a groin transection model in swine. J Trauma. 2009;67:848-855.
33. Arnaud F, Teranishi K, Okada T, et al. Comparison of Combat Gauze and TraumaStat in two severe groin injury models. J Surg Res. 2011;169: 92-98.
34. Kheirabadi BS, Scherer MR, Estep JS, et al. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma. 2009;67:450-459; discussion 459-460.
35. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine. J Trauma. 2010;68:269-278.
36. Kheirabadi BS, Acheson EM, Deguzman R, et al. Hemostatic efficacy of two advanced dressings in an aortic hemorrhage model in Swine. J Trauma. 2005;59:25-34; discussion 34-35.
37. Parr MJ, Bouillon B, Brohi K, et al. Traumatic coagulopathy: where are the good experimental models? J Trauma. 2008;65:766-771.